| Cyclic
Sulfamidates as Enantiomerically Pure Building Blocks for Heterocyclic
Synthesis |
|
NEWS: John
Bower has applied cyclic sulfamidate methodology to the successful synthesis
of (i) (-)- Paroxetine (ii) (+)-laccarin and most recently (iii) Levofloxacin (Org.
Lett.; 2007, 9, 3283-3286).
This is
the first synthesis of laccarin and has allowed us to assign the
absolute stereochemistry of this natural product. This work is
was published in Chem Commun in 2007.

John has
also recently completed the synthesis of (-)-aphanorphine in a
very direct and efficient manner, key features of which are illustrated
below.

Background:
Asymmetric Piperidine Synthesis via 1,3-Cyclic Sulfates
The advent of the
Sharpless asymmetric dihydroxylation was rapidly followed by the development
of chemistry associated with the corresponding 1,2-cyclic sulfates.
These reactive C2 units are synthetically equivalent to epoxides
since the two adjacent carbon centres each carry a (potential) leaving
group. In the case of the cyclic sulfate, initial nucleophilic attack
(and ring cleavage) produces an intermediate – a sulfate –OSO3-
that is already activated towards a second nucleophilic displacement.
The synthesis
of sedridine relied on constructing a 1,3-cyclic sulfate capable
of undergoing ONE alkylation step as a means of generating a
piperidine ring.
The synthesis
of coniine, the famous hemlock alkaloid- see
right and Socarates (below) whose fate was sealed by hemlock
- and much-used vehicle for the exemplification of new asymmetric
methodology, takes this chemistry that step further.
Here we
have used a C,N-dianion (based on an N-sulfonyl a-sulfonyl
acetamide) as one component and the enantiomerically pure (>95%
e.e.) 1,3-cyclic sulfate as the other half of the new piperidine
ring.
|
|
CURRENT
WORK - The Chemistry of Cyclic Sulfamidates
We
are now focussed on developing this methodology in a number of
directions. Of particular importance, given our interest in heterocyclic
chemistry, is the synthetic chemistry of 1,2- and 1,3-cyclic sulfamidates.
Both
1,2- and 1,3-cyclic sulfamidates are readily prepared from 1,2-
and 1,3-amino alcohols (often from the corresponding amino acids)
and function as synthetic equivalents of aziridines and azetidines.
|
|
These
systems also offer advantages over cyclic sulfates for heterocyclic
synthesis. Constructing nitrogen heterocycles via a cyclic sulfate requires
generating a new C-N - look at the coniine example above – and
this nucleophilic displacement can be “problematic” in terms
of the levels of enantiospecificity observed – complete stereochemical
integrity is difficult to achieve. With a cyclic sulfamidate, then the
key C-N bond is already there and the regioselectivity of nucleophilic
attack – at the O vs the N centre - is clear cut: The C-O bond
is cleaved preferentially.
Using
a range of cyclic sulfamidates, we have employed a number of nucleophiles
based on a-heteroatom substituted esters
or more recently functionalised enolates. These systems serve to (i)
ring open the cyclic sulfamidate and (ii) a subsequent cyclisation hen
generates the N-heterocycle (as a lactam).
Work in this area is now focussed on defining the scope of this chemistry
– the range of nucleophiles that can be used and the downstream
chemistry that is then available. Using heteroatoms as nucleophiles,
we have defined routes of various heterocycles (piperazines and thiomorpholines)
and the chemistry is very tolerant of potentially sensitive stereocentres.

We have also used carbon based nucleophiles - stabilised enolates -
to incorporate a broad range of functionality within a substituted pyrrolidine
or piperidine framework. Current work is focussed on the application
of cyclic sulfamidates to interesting and challenging natural product
targets, such as (-)-aphanorphine (see NEWS above)
and saxitoxin.